Key Highlights
Technical Challenges: The synthesis of Active Pharmaceutical Ingredients (APIs) and intermediates involves complex processes, subject to exacting requirements regarding impurity control and regulatory documentation.
Boweixin’s Product Matrix: We have established a comprehensive portfolio of pharmaceutical intermediates, anchored by key product lines in oncology, cardiovascular medicine, and antiviral therapies.CAS 675126-26-8, chemically known as 4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile, is a critical building block and impurity standard primarily used in the synthesis and quality control of Gefitinib (an EGFR inhibitor for NSCLC). We provide high-purity grades of this compound with comprehensive analytical data (HPLC, NMR, LC-MS) to support your pharmaceutical R&D and API manufacturing needs.
Service Features
From Lab-Scale R&D to Pilot-Scale Upscaling: Accelerating the development cycle for pharmaceutical companies—from initial molecular discovery to full-scale commercial production.
One-Stop Compliance Services: Providing comprehensive technical support to ensure compliance with market entry standards for major global markets, including Europe and North America.
Value Proposition: Driven by highly competitive pricing and efficient supply chain management, we have become a trusted long-term partner for numerous pharmaceutical laboratories and manufacturing facilities worldwide.